RABBANI ELAZAR 4
4 · ENZO BIOCHEM INC · Filed Jan 19, 2018
Insider Transaction Report
Form 4
RABBANI ELAZAR
DirectorChairman and CEO
Transactions
- Tax Payment
Common Stock
2018-01-17$7.75/sh−14,534$112,639→ 1,838,668 total - Exercise/Conversion
Stock Option (to acquire common stock)
2018-01-17−38,505→ 222,249 totalExercise: $2.88From: 2014-01-17Exp: 2018-01-17→ Common Stock (38,505 underlying) - Exercise/Conversion
Common Stock
2018-01-17$2.88/sh+38,505$110,894→ 1,867,202 total - Sale
Common Stock
2018-01-17$7.75/sh−14,000$108,500→ 1,853,202 total
Footnotes (3)
- [F1]Represents shares sold to satisfy reporting person's tax obligations.
- [F2]Represents shares withheld by the company to cover the exercise price of the Stock Options.
- [F3]The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.